12:00 AM
 | 
Dec 07, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zyprexa olanzapine regulatory update

FDA approved sNDAs from Eli Lilly for oral Zyprexa olanzapine to treat schizophrenia and manic or mixed episodes associated...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >